Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sherven Sharma

Showing results (101-110 of 103) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 103 results.
Cancer Research|May 31, 2019
The Immune Contexture Associates with the Genomic Landscape in Lung Adenomatous PremalignancyKostyantyn Krysan, Linh M Tran, Brandon S Grimes, et al.
Cancer Research|February 13, 2018
Silencing the Snail-Dependent RNA Splice Regulator ESRP1 Drives Malignant Transformation of Human Pulmonary Epithelial CellsTonya C Walser, Zhe Jing, Linh M Tran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2017
Phase I Trial of Intratumoral Injection of <i>CCL21</i> Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8<sup>+</sup> T-cell InfiltrationJay M Lee, Mi-Heon Lee, Edward Garon, et al.
Pageof 11

Showing results (101-110 of 103) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 103 results.
Cancer Research|May 31, 2019
The Immune Contexture Associates with the Genomic Landscape in Lung Adenomatous PremalignancyKostyantyn Krysan, Linh M Tran, Brandon S Grimes, et al.
Cancer Research|February 13, 2018
Silencing the Snail-Dependent RNA Splice Regulator ESRP1 Drives Malignant Transformation of Human Pulmonary Epithelial CellsTonya C Walser, Zhe Jing, Linh M Tran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2017
Phase I Trial of Intratumoral Injection of <i>CCL21</i> Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8<sup>+</sup> T-cell InfiltrationJay M Lee, Mi-Heon Lee, Edward Garon, et al.
Pageof 11